5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Navigating the challenges of the COVID-19 outbreak: perspectives from the radiation oncology service in singapore

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Highlights

          • Unique considerations for radiation department operating during Covid-19 outbreak.

          • Highlights the challenges of radiation departments providing care during a pandemic in Singapore.

          • Highlights practical steps on handling oncology patients during infectious outbreak

          Abstract

          In December 2019, pneumonia of unknown cause was reported by China to WHO. The outbreak was found to be caused by a coronavirus which was officially named “severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2), and the disease caused by it was named ‘COVID-19’. The first case in Singapore was confirmed on 23 rd January 2020. With lessons learnt from the SARS epidemic in 2003 and the H1N1 flu pandemic in 2009, Singapore was much better prepared to deal with the virus outbreak. The government has taken swift measures to contain and break the chain of transmission. Healthcare workers face the challenge of keeping patients and staff safe from the disease. There is a higher risk of mortality of COVID-19 in cancer patients and hence unique considerations for a radiation oncology department operating in an infectious disease outbreak. This article is the recommendations and adapted workflow from the two National Cancer Centres in Singapore with the endorsement by the working committee of the Chapter of Radiation Oncology, Academy of Medicine, Singapore. It highlights the challenges that radiation oncology departments in Singapore face and the appropriate recommended responses. This includes interventions, business continuity plans and workflow in managing a COVID-19 positive patient on radiotherapy.

          Related collections

          Most cited references4

          • Record: found
          • Abstract: found
          • Article: not found

          Loss of local control with prolongation in radiotherapy.

          Twelve published clinical results of radical radiotherapy of head and neck cancer have been reviewed, seven of them with fresh multivariate analyses, to determine the magnitude of time factors relating local control to overall time. In all but two of the data sets a significant loss of local control was observed with prolongation. The median rate of loss was 14% in only 1 week, the range 3 to 25%. This corresponds to a median loss of 26% in 2 weeks (5-42%). These results are comparable with other, less detailed information. Whether these significant losses are due to proliferation of tumor cells or to other causes such as physician selection, it is clear that modest prolongation is associated with a lower chance of local control.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Severe Acute Respiratory Syndrome: Lessons from Singapore

            An outbreak of severe acute respiratory syndrome (SARS) occurred in Singapore in March 2003. To illustrate the problems in diagnosing and containing SARS in the hospital, we describe a case series and highlight changes in triage and infection control practices that resulted. By implementing these changes, we have stopped the nosocomial transmission of the virus.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): a Chinese perspective

                Bookmark

                Author and article information

                Contributors
                Journal
                Radiother Oncol
                Radiother Oncol
                Radiotherapy and Oncology
                Elsevier B.V.
                0167-8140
                1879-0887
                31 March 2020
                31 March 2020
                :
                Affiliations
                [a ]Department of Radiation Oncology, National University Cancer Institute, Singapore
                [b ]Division of Radiation Oncology, National Cancer Centre Singapore, Singapore
                [c ]ICON Cancer Center, Department of Radiation Oncology, Farrer Park Hospital, Singapore
                [d ]Academic Clinical Program Oncology, Duke NUS Graduate Medical School, Singapore
                Author notes
                [* ]Corresponding author at: Senior Consultant Radiation Oncologist, Chair, Chapter of Radiation Oncology, Academy of Medicine, Singapore bokaichoo@ 123456gmail.com
                [1]

                Jeremy Tey and Shaun Ho contributed equally for this paper

                Article
                S0167-8140(20)30164-X
                10.1016/j.radonc.2020.03.030
                7118656
                32342873
                55e45353-6001-4b2f-8ad0-371bb5d9fb67
                © 2020 Elsevier B.V. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 21 March 2020
                : 24 March 2020
                : 24 March 2020
                Categories
                Article

                Oncology & Radiotherapy
                covid-19,sars-cov-2,pandemic,infection control,guidelines
                Oncology & Radiotherapy
                covid-19, sars-cov-2, pandemic, infection control, guidelines

                Comments

                Comment on this article